Signbro Pharma Private Limited
About Signbro Pharma Private Limited
Data last updated:
Signbro Pharma Private Limited is a private limited company based in Coimbatore, Tamil Nadu, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 29 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U24290TZ2020PTC034861. Its GSTIN is 33ABECS7812E1ZJ (Tamil Nadu).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Murugesan Rajini and Duraisamy Sundararajan Gayathri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No: 24/B Lakshmi Puram Rathinapuri Ganbathy Village, Coimbatore, Tamil Nadu, India – 641006.
As per the financials filed for FY 2024, the company reported a revenue of ₹23.23 Lakh, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹1.46 Lakh (net margin 6.3%) and EBITDA of ₹2.23 Lakh (EBITDA margin 9.6%).
Company details
CIN history
Signbro Pharma has one previous CIN (Corporate Identification Number): U24290TZ2020OPC034861. The current CIN is U24290TZ2020PTC034861, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24290TZ2020PTC034861 | Current |
| U24290TZ2020OPC034861 | Previous |
Contact details
Signbro Pharma Private Limited's registered office is in Coimbatore, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressNo: 24/B Lakshmi Puram Rathinapuri Ganbathy Village, Coimbatore, Tamil Nadu, India – 641006
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Signbro Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Signbro Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Signbro Pharma Private Limited, buy the company report.
Financials of Signbro Pharma Private Limited
FY 2025 filings availableSignbro Pharma Private Limited reported revenue of ₹23.23 Lakh (up 26% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 26% in the latest year. EBITDA rose 77% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.23 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.46 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 9.6% | |||
| Net Profit Margin | 6.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Signbro Pharma Private Limited, buy the company report.
Board of directors of Signbro Pharma Private Limited
Signbro Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murugesan Rajini | Director | 24 Jan 2024 | 2 Years 9 Months | Current |
| Duraisamy Sundararajan Gayathri Also directs: Zetmax Pharma Private Limited | Director | 29 Oct 2020 | 5 Years 11 Months | Current |
Peer comparison
Signbro Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gau Urja Health Services Private Limited | ₹23.45 Lakh (FY 2025) | -15.0% | Vaduj, Maharashtra, India | |||
| White Tusk Healthcare Private Limited | ₹23.44 Lakh (FY 2025) | 339.0% | Mumbai, Maharashtra, India | |||
| Ray Biolab Private Limited | ₹23.43 Lakh (FY 2022) | 63.0% | Thane, Maharashtra, India | |||
| SNS Endeavour Private Limited | ₹23.41 Lakh (FY 2024) | -80.0% | Tiruvallur, Tamil Nadu, India | |||
| Baayoju Healthcare Private Limited | ₹23.37 Lakh (FY 2025) | -14.0% | Hyderabad, Telangana, India | |||
| Signbro Pharma Private Limitedthis company | ₹23.23 Lakh (FY 2024) | ₹1.46 Lakh | 6.3% | 26.0% | Coimbatore, Tamil Nadu, India | |
| Peringode Ayurveda Kendram Private Limited | ₹23.18 Lakh (FY 2024) | 36.0% | Peringode, Kerala, India | |||
| Iyengaran Faith Care Centre Private Limited (OPC) | ₹23.16 Lakh (FY 2025) | 334.0% | Madurai, Tamil Nadu, India | |||
| Trustandhoperad Private Limited | ₹23.14 Lakh (FY 2024) | Bangalore, Karnataka, India | ||||
| Yoklient Techno-Commercial Services Private Limited | ₹23.13 Lakh (FY 2020) | Surat, Gujarat, India | ||||
| Meridian Projects Limited | ₹23.11 Lakh (FY 2025) | 15.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Signbro Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Signbro Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Signbro Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Signbro Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33ABECS7812E1ZJ | Tamil Nadu | Active | 17 Nov 2020 |
To see the full GST registrations and return filing status of Signbro Pharma Private Limited, buy the company report.
Recent activity
Signbro Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Murugesan Rajini was appointed as Director on 24 Jan 2024.
Frequently asked questions
Signbro Pharma is an active private limited company based in Coimbatore, Tamil Nadu, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 29 October 2020 (6+ years old) and is registered under CIN U24290TZ2020PTC034861.
Signbro Pharma has 2 current directors:
- Murugesan Rajini - Director
- Duraisamy Sundararajan Gayathri - Director
The latest financial statements of Signbro Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Signbro Pharma is 33ABECS7812E1ZJ, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Signbro Pharma is U24290TZ2020PTC034861. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Signbro Pharma was incorporated on 29 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Coimbatore.
The peers of Signbro Pharma by revenue are Gau Urja Health Services Private Limited, White Tusk Healthcare Private Limited, Ray Biolab Private Limited, SNS Endeavour Private Limited, Baayoju Healthcare Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Murugesan Rajini was appointed as Director on 24 Jan 2024. Duraisamy Sundararajan Gayathri was appointed as Director on 29 Oct 2020.
The registered office of Signbro Pharma is at No: 24B Lakshmi Puram Rathinapuri Ganbathy Village, Coimbatore, Tamil Nadu, India – 641006.
Signbro Pharma operates in the chemicals industry, in the manufacturing segment.
Signbro Pharma can be reached at its registered office: No: 24B Lakshmi Puram Rathinapuri Ganbathy Village, Coimbatore, Tamil Nadu, India – 641006.